Maëlle Chausse focuses her practice on all aspects of employment law including contentious, advisory and transactional matters. Ms. Chausse is also a member of Dechert’s Privacy & Cybersecurity group. Ms. Chausse counsels French and other global clients on matters arising at all stages of employment, including the handling of negotiated exits. She also assists companies on all labor-related steps of mergers and acquisitions transactions.

Ms. Chausse provides strategic data privacy advice to companies in a wide array of sectors and industries, under French and EU data protection legislation, with a particular focus on leveraging data assets to achieve business objectives in a global digital economy. Her work includes advising clients on cross-border data transfers and conducting privacy due diligence in M&A and other commercial transactions. She also prepares data protection notices and data retention policies on behalf of her clients. Ms. Chausse advises clients on a variety of workplace privacy matters, including employee monitoring and social media use policies. 

Along with Dechert partner Philippe Thomas, she recently authored “French Q&As regarding restrictive covenants clauses” for Thomson Reuters Practical Law

Prior to joining Dechert, Ms. Chausse served as a labor and employment trainee and associate at both French and international law firms.

    • A leading supplier of beverage, food and aerosol packaging, metal closures, specialty packaging products and transit and protective packaging products, equipment and services in its pending €1.9 billion sale of its EMEA tinplate business.
    • Several Medtechs in their data protection policies and in their handling of health data.
    • An American private equity fund, in connection with its investment in a French group, leader of tailored travel and adventure travel.
    • A consortium of investors, on a seed financing round for a French start-up specialized in Digital Therapeutics (DTx), which are digital solutions for the prevention, management and treatment of a broad range of medical conditions, with a view to create the first digital molecule. 
    • Medical visitors: home occupation allowance is not systematic – L’Usine Nouvelle (July 2020)
    • Adoption by the European Commission of new SCCs: what impact for your data transfers? L’Usine Nouvelle (July 2021)